ALPS Advisors’s AnaptysBio ANAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$352K Sell
15,863
-7,263
-31% -$161K ﹤0.01% 866
2025
Q1
$430K Sell
23,126
-1,478
-6% -$27.5K ﹤0.01% 611
2024
Q4
$326K Buy
24,604
+3,092
+14% +$40.9K ﹤0.01% 840
2024
Q3
$721K Buy
21,512
+183
+0.9% +$6.13K ﹤0.01% 564
2024
Q2
$535K Buy
21,329
+2,582
+14% +$64.7K ﹤0.01% 565
2024
Q1
$422K Buy
18,747
+679
+4% +$15.3K ﹤0.01% 617
2023
Q4
$387K Sell
18,068
-1,506
-8% -$32.3K ﹤0.01% 694
2023
Q3
$352K Buy
19,574
+104
+0.5% +$1.87K ﹤0.01% 653
2023
Q2
$396K Buy
19,470
+1,071
+6% +$21.8K ﹤0.01% 661
2023
Q1
$400K Sell
18,399
-887
-5% -$19.3K ﹤0.01% 619
2022
Q4
$598K Buy
19,286
+3,917
+25% +$121K 0.01% 556
2022
Q3
$392K Sell
15,369
-1,352
-8% -$34.5K ﹤0.01% 661
2022
Q2
$339K Sell
16,721
-11,718
-41% -$238K ﹤0.01% 711
2022
Q1
$704K Sell
28,439
-3,392
-11% -$84K 0.01% 351
2021
Q4
$1.11M Sell
31,831
-1,792
-5% -$62.3K 0.01% 349
2021
Q3
$912K Sell
33,623
-2,422
-7% -$65.7K 0.01% 400
2021
Q2
$935K Sell
36,045
-13,429
-27% -$348K 0.01% 407
2021
Q1
$1.07M Buy
49,474
+122
+0.2% +$2.63K 0.01% 390
2020
Q4
$1.06M Buy
49,352
+14,538
+42% +$313K 0.01% 384
2020
Q3
$514K Sell
34,814
-2,396
-6% -$35.4K 0.01% 426
2020
Q2
$831K Buy
+37,210
New +$831K 0.01% 363
2019
Q4
Sell
-53,927
Closed -$1.89M 817
2019
Q3
$1.89M Sell
53,927
-2,636
-5% -$92.2K 0.01% 214
2019
Q2
$3.19M Sell
56,563
-8,053
-12% -$454K 0.02% 185
2019
Q1
$4.72M Buy
64,616
+2,797
+5% +$204K 0.03% 171
2018
Q4
$3.94M Buy
61,819
+19,284
+45% +$1.23M 0.03% 175
2018
Q3
$4.24M Buy
42,535
+8,441
+25% +$842K 0.03% 178
2018
Q2
$2.42M Buy
34,094
+2,579
+8% +$183K 0.02% 214
2018
Q1
$3.28M Buy
31,515
+5,477
+21% +$570K 0.03% 173
2017
Q4
$2.62M Buy
26,038
+6,004
+30% +$605K 0.02% 179
2017
Q3
$700K Buy
20,034
+1,824
+10% +$63.7K 0.01% 309
2017
Q2
$436K Buy
+18,210
New +$436K ﹤0.01% 631